The startup world is changing! [Link] Startups in “hard sciences” like biology or chemistry are now getting the attention they deserve from big investors and Fortune 500 companies....
Immunotherapy has evolved rapidly from first promising clinical results to nothing short of revolutionizing therapy in various cancer indications. On almost a daily basis do we learn about progress in both single and combination therapies for not only disease management but lasting remissions and even...
Dear Colleagues, Over the past few years, we have seen major advancements in oncology propelled by increasing molecular and cellular mechanistic insights and applications of Precision Medicine. Tailored treatment for BRCA-positive mutation carriers and breast cancer patients is available. Disease identification and characterization is occurring. Patient...
Does Immunotherapy Measure Up to the Hype? Brigitte Ganter, PhD Disclosures | October 27, 2016 Editor’s Note: The emergence of immunotherapy has redefined cancer medicine. Among those who continue to redefine this expanding arena of clinical research, James P. Allison, PhD, of MD Anderson Cancer Center, holds a special place....
Dr. James Allison of MD Anderson Cancer Center, considered by many to be the “father of immunotherapy” is a recipient of the PMWC 2017 Pioneer Award. In his interview published earlier this week on Medscape highlighted some of the key focus areas of PMWC 2017...
In contrast to the three traditional pillars of cancer treatment (surgery, radiotherapy, and chemotherapy), cancer immunotherapy is a relatively young field, yet it is considered a huge game-changer - as it is in the process of changing how we treat cancer. Immunotherapy is rapidly becoming part...
